What's new

Opinion/decision on a Paediatric investigation plan (PIP): Eliquis, Apixaban, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0135/2024

Opinion/decision on a Paediatric investigation plan (PIP): Eliquis, Apixaban, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0135/2024

Jun 11, 2025 - 15:05
 0
Opinion/decision on a Paediatric investigation plan (PIP): Eliquis, Apixaban, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0135/2024
Opinion/decision on a Paediatric investigation plan (PIP): Eliquis, Apixaban, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0135/2024
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Dexdor, dexmedetomidin...

Next Article

EMEA-003623-PIP01-24

Related Posts

Training session for patients, consumers and healthcare professionals involved in medicine regulatory activities July 2025, European Medicines Agency, Amsterdam, the Netherlands, from 2 July 2025, 09:30 (CEST) to 2 July 2025, 16:15 (CEST)

Training session for patients, consumers and healthcare...

May 22, 2025  0

EVVET – Data warehouse user manual

May 16, 2025  0

Scientific advice and protocol assistance adopted durin...

May 14, 2025  0